amiodarone has been researched along with Kidney Diseases in 12 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone inhibits warfarin metabolism and is associated with major bleeding during warfarin therapy." | 3.96 | The Magnitude of the Warfarin-Amiodarone Drug-Drug Interaction Varies With Renal Function: A Propensity-Matched Cohort Study. ( Brown, JR; Hennessy, S; Miano, TA; Shashaty, MGS; Yang, W; Zuppa, A, 2020) |
| "Rivaroxaban (RXA) is a direct oral factor Xa (Xa) antagonist with a short half-life and a fast onset and offset of effect." | 1.48 | Risk Factors for Higher-than-Expected Residual Rivaroxaban Plasma Concentrations in Real-Life Patients. ( Jetter, A; Kaserer, A; Schedler, A; Seifert, B; Spahn, DR; Stein, P; Studt, JD, 2018) |
| "Rats treated with amiodarone had a higher serum creatinine (182%) and a lower glomerular filtration rate (53%), renal plasma flow (68%) and filtration fraction (62%) than controls." | 1.32 | Acute renal toxic effect of amiodarone in rats. ( Arévalo, MA; Barata, JD; Branco, P; Bruges, M; González de Buitrago, JM; Morales, AI; Palma, P; Pérez-Barriocanal, F, 2003) |
| "To understand the bioavailability and mechanistic pathways of cytoprotection by IH636 grape seed proanthocyanidin extract (GSPE, commercially known as ActiVin) a series of in vitro and in vivo studies were conducted." | 1.31 | Mechanistic pathways of antioxidant cytoprotection by a novel IH636 grape seed proanthocyanidin extract. ( Bagchi, D; Bagchi, M; Preuss, HG; Ray, SD; Stohs, SJ, 2002) |
| " The data were analyzed by nonlinear mixed-effects modeling (NONMEM) to estimate the population pharmacokinetic parameters of amiodarone and to determine the significant demographic covariates affecting these parameters." | 1.30 | Population pharmacokinetics of intravenous amiodarone and comparison with two-stage pharmacokinetic analysis. ( Chiang, ST; Korth-Bradley, J; Troy, S; Vadiei, K; Zimmerman, JJ, 1997) |
| " Also, no difference in efficacy of either drug was observed and changes in dosing of digoxin were not required." | 1.27 | Drug interaction studies and encainide use in renal and hepatic impairment. ( Gallo, DG; Quart, BD; Sami, MH; Wood, AJ, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Miano, TA | 1 |
| Yang, W | 1 |
| Shashaty, MGS | 1 |
| Zuppa, A | 1 |
| Brown, JR | 1 |
| Hennessy, S | 1 |
| Rabia, M | 1 |
| Leuzy, V | 1 |
| Soulage, C | 1 |
| Durand, A | 1 |
| Fourmaux, B | 1 |
| Errazuriz-Cerda, E | 1 |
| Köffel, R | 1 |
| Draeger, A | 1 |
| Colosetti, P | 1 |
| Jalabert, A | 1 |
| Di Filippo, M | 1 |
| Villard-Garon, A | 1 |
| Bergerot, C | 1 |
| Luquain-Costaz, C | 1 |
| Moulin, P | 1 |
| Rome, S | 1 |
| Delton, I | 1 |
| Hullin-Matsuda, F | 1 |
| Kaserer, A | 1 |
| Schedler, A | 1 |
| Jetter, A | 1 |
| Seifert, B | 1 |
| Spahn, DR | 1 |
| Stein, P | 1 |
| Studt, JD | 1 |
| Jamshidzadeh, A | 1 |
| Baghban, M | 1 |
| Azarpira, N | 1 |
| Mohammadi Bardbori, A | 1 |
| Niknahad, H | 1 |
| Bagchi, D | 2 |
| Ray, SD | 2 |
| Bagchi, M | 1 |
| Preuss, HG | 1 |
| Stohs, SJ | 1 |
| Morales, AI | 1 |
| Barata, JD | 1 |
| Bruges, M | 1 |
| Arévalo, MA | 1 |
| González de Buitrago, JM | 1 |
| Palma, P | 1 |
| Branco, P | 1 |
| Pérez-Barriocanal, F | 1 |
| Pintavorn, P | 1 |
| Wartofsky, L | 1 |
| Burman, KD | 1 |
| Vadiei, K | 1 |
| Troy, S | 1 |
| Korth-Bradley, J | 1 |
| Chiang, ST | 1 |
| Zimmerman, JJ | 1 |
| Patel, D | 1 |
| Wong, V | 1 |
| Quart, BD | 1 |
| Gallo, DG | 1 |
| Sami, MH | 1 |
| Wood, AJ | 1 |
| Caubarrère, I | 1 |
| Bonan, G | 1 |
| Venet, A | 1 |
| Chebat, J | 1 |
| Uzzan, D | 1 |
| Gilbert, J | 1 |
| Beaufils, H | 1 |
1 review available for amiodarone and Kidney Diseases
| Article | Year |
|---|---|
Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome".
Topics: Adult; Age Factors; Aged; Amiodarone; Animals; Anorexia Nervosa; Contrast Media; Diabetes Mellitus; | 1982 |
11 other studies available for amiodarone and Kidney Diseases
| Article | Year |
|---|---|
The Magnitude of the Warfarin-Amiodarone Drug-Drug Interaction Varies With Renal Function: A Propensity-Matched Cohort Study.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Co | 2020 |
Bis(monoacylglycero)phosphate, a new lipid signature of endosome-derived extracellular vesicles.
Topics: Aged; Amiodarone; Animals; Anti-Arrhythmia Agents; Biomarkers; Endosomes; Extracellular Vesicles; Fe | 2020 |
Risk Factors for Higher-than-Expected Residual Rivaroxaban Plasma Concentrations in Real-Life Patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Blood Coagulation | 2018 |
Effects of tomato extract on oxidative stress induced toxicity in different organs of rats.
Topics: Acetaminophen; Amiodarone; Analgesics, Non-Narcotic; Animals; Anti-Arrhythmia Agents; Chemical and D | 2008 |
Mechanistic pathways of antioxidant cytoprotection by a novel IH636 grape seed proanthocyanidin extract.
Topics: Acetaminophen; Administration, Oral; Alanine Transaminase; Amiodarone; Analgesics, Non-Narcotic; Ani | 2002 |
Acute renal toxic effect of amiodarone in rats.
Topics: Acute Disease; Amiodarone; Animals; Anti-Arrhythmia Agents; Creatinine; Injections, Intraperitoneal; | 2003 |
A wild zebra chase.
Topics: Amiodarone; Animals; Diagnosis, Differential; Fabry Disease; Female; Humans; Iatrogenic Disease; Kid | 2008 |
Population pharmacokinetics of intravenous amiodarone and comparison with two-stage pharmacokinetic analysis.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Injections, Intr | 1997 |
In vivo protection of dna damage associated apoptotic and necrotic cell deaths during acetaminophen-induced nephrotoxicity, amiodarone-induced lung toxicity and doxorubicin-induced cardiotoxicity by a novel IH636 grape seed proanthocyanidin extract.
Topics: Acetaminophen; Administration, Oral; Alanine Transaminase; Amiodarone; Animals; Antioxidants; Apopto | 2000 |
Drug interaction studies and encainide use in renal and hepatic impairment.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anilides; Anti-Arrhythmia Agents; Anticoagulants; An | 1986 |
[Pneumopathies caused by hypersensitivity to amiodarone and associated nephropathies. Study by alveolar lavage].
Topics: Acute Kidney Injury; Aged; Amiodarone; Benzofurans; Drug Hypersensitivity; Female; Humans; Kidney Di | 1985 |